BioNexus Gene Lab Corp Common stock (BGLC)vsBHP Group Limited (BHP)
BGLC
BioNexus Gene Lab Corp Common stock
$1.32
0.00%
BASIC MATERIALS · Cap: $3.72M
BHP
BHP Group Limited
$84.49
-1.64%
BASIC MATERIALS · Cap: $204.85B
Smart Verdict
WallStSmart Research — data-driven comparison
BHP Group Limited generates 1016489% more annual revenue ($53.99B vs $5.31M). BHP leads profitability with a 19.0% profit margin vs -54.7%. BHP earns a higher WallStSmart Score of 65/100 (C+).
BGLC
Avoid29
out of 100
Grade: F
BHP
Buy65
out of 100
Grade: C+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Mega-cap, among the largest globally
Every $100 of equity generates 43 in profit
Strong operational efficiency at 40.7%
Earnings expanding 27.5% YoY
Generating 4.3B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -35.9% — below average capital efficiency
Revenue declined 98.9%
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : BGLC
The strongest argument for BGLC centers on Price/Book, Debt/Equity, Altman Z-Score.
Bull Case : BHP
The strongest argument for BHP centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 19.0% and operating margin at 40.7%. Revenue growth of 10.8% demonstrates continued momentum.
Bear Case : BGLC
The primary concerns for BGLC are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : BHP
The primary concerns for BHP are Piotroski F-Score, PEG Ratio.
Key Dynamics to Monitor
BGLC profiles as a turnaround stock while BHP is a mature play — different risk/reward profiles.
BGLC carries more volatility with a beta of 2.21 — expect wider price swings.
BHP is growing revenue faster at 10.8% — sustainability is the question.
BHP generates stronger free cash flow (4.3B), providing more financial flexibility.
Bottom Line
BHP scores higher overall (65/100 vs 29/100), backed by strong 19.0% margins and 10.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BioNexus Gene Lab Corp Common stock
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
BHP Group Limited
BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA
BHP Group engages in the natural resources business in Australia, Europe, China, Japan, India, South Korea, the rest of Asia, North America, South America and internationally. The company is headquartered in Melbourne, Australia.
Compare with Other SPECIALTY CHEMICALS Stocks
Want to dig deeper into these stocks?